2020 | MD Anderson Cancer Center

November 23, 2020

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks...

November 18, 2020

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced a multi-year strategic collaboration...

November 11, 2020

ABSTRACTS 277, 368, 420

Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight...

November 05, 2020

Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of...

October 20, 2020

The Focus Fund GP, LLC, in partnership with The University of Texas MD Anderson Cancer Center, has launched Cancer Focus Fund, LP, an...

September 08, 2020

The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical...

March 01, 2020

The University of Texas MD Anderson Cancer Center is preparing to return to normal operations on Monday morning, March 2, after...

Help #EndCancer